Navigation Links
Nanomedicine Market Expected to Grow at a CAGR of 12.57% by 2016 in New Research Report at RnRMarketResearch.com
Date:8/10/2013

Dallas, TX (PRWEB) August 10, 2013

This report forecasts the Global Nanomedicine market to grow at a CAGR of 12.57 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of nanorobotics. The Global Nanomedicine market has also witnessed the increasing use of novel nanomaterials. However, lengthy approval procedures could pose a challenge to the growth of this market.

Get a copy of this report at http://www.rnrmarketresearch.com/global-nanomedicine-market-2012-2016-market-report.html.

This report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Nanomedicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, Bristol-Myers Squibb Co., Celgene Corp., GlaxoSmithKline plc, and Pfizer Inc.

The other vendors mentioned in this report are Ablynx NV, Acusphere Inc., Aphios Corp., Arrowhead Research Corp., BioForce, Nanosciences Holdings Inc., Bio-Gate AG, Biophan Technologies Inc., BioSante Pharmaceuticals Inc., CombiMatrix Corp., Enzon Pharmaceuticals Inc., GE Healthcare Ltd., Gilead Sciences Inc., IDEX Corp., IGI Laboratories Inc., Kereos Inc., Kimberly-Clark Corp., MIV Therapeutics Inc., Nanobiotix S.A., NanoCarrier Co. Ltd., Nanogen Inc., NanoLogix Inc., NanoMed Pharmaceuticals Inc., Nanotherapeutics Inc., NanoViricides Inc., Paladin Labs Inc., pSivida Corp., Qiagen N.V., Roche Holding AG, Skyepharma PLC, Smith & Nephew plc, Starpharma Holdings Ltd., Stryker Corp., and Tecan Group Ltd.

Key questions answered in this report:

What will the market size be in 2016 and what will be the growth rate?

What are key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by key vendors?

What are the strengths and weaknesses of each of these key vendors?

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=109131.

Browse more reports on Nanomedicine Market at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/nanomedicine.

About Us:
RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/2016-nanomedicine-market/analysis-and-forecasts/prweb11009655.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New nanomedicine resolves inflammation, promotes tissue healing
2. Clearing up inflammation with pro-resolving nanomedicines
3. Researchers pioneer worlds first HIV/AIDS nanomedicines
4. First targeted and programmable nanomedicine to show clinical antitumor effects published
5. Global Lung Cancer Therapeutics Market 2013 Report Featuring Leading Players Such As AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline, Hoffmann-La Roche, Novartis And Others
6. Neuroprotection - Drugs, Markets and Companies - Updated 2013 Report with Extra Company Collaborations
7. Oncology Therapeutics Market in India to 2018 Report
8. Epigenetic and MicroRNA Biomarkers 2013 Market Report
9. The Global Next Generation Sequencing (NGS) Market is Poised to Reach $2.7 Billion by 2017 Says Latest Report
10. Microbes Market and Microbial Products Reviewed in New Research Report at ReportsnReports.com
11. The Global Surgical Equipment Market to Grow At A CAGR Of 6.25 Percent over the Period 2012-2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology:
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
Breaking Biology News(10 mins):